Pfizer BioNTech COVID-19 Vaccine

Share this story on:

Share on facebook
Share on twitter
Share on linkedin

“This vaccine is authorized for emergency use in persons age 16 years and older.  This is a two-dose vaccine, given 21 days apart.  Clinical trial data show the vaccine is 95% effective at preventing COVID-19 infection starting 7 days after the 2nd dose.  Individual will not be considered fully protected until 2 weeks after the y receive the 2nd dose.  The clinical trials revealed no major unanticipated adverse events.  This vaccine arrived in Washington (state) on December 14th.”

-Washington State Department of Health

Teresa
Teresa

Recent Posts

Teresa

Update: Full Vax Against COVID

Update:  As of 4/30/21: Indiana= 1.76 million residents.  26.25% of state population. Kentucky= 1.40 million residents.  31.34% of state population. Florida= 6.13 million residents.  28.57%

Read More »
Teresa

Indiana Update

Over 954,000 people in the state of Indiana have been fully vaccinated against COVID-19. There are 548 people in Indiana hospitals because of COVID-19; and

Read More »
Teresa

Unprecedented Collaboration

“… COVID 19 has led to unprecedented worldwide collaboration among scientists, medical doctors, health and government officials, and manufacturers…The arrival of this vaccine in Michigan

Read More »

copyright 2020 Evansville Insurance Center